Zeke Capital Advisors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-180,000
| Closed | -$1.57M | – | 536 |
|
|
2022
Q1 | $1.57M | Sell |
180,000
-413,656
| -70% | -$3.6M | 0.08% | 106 |
|
|
2021
Q4 | $5.65M | Sell |
593,656
-130,021
| -18% | -$1.24M | 0.33% | 34 |
|
|
2021
Q3 | $12.2M | Buy |
723,677
+802
| +0.1% | +$13.5K | 0.7% | 29 |
|
|
2021
Q2 | $11M | Buy |
722,875
+205,769
| +40% | +$3.14M | 0.7% | 33 |
|
|
2021
Q1 | $10.1M | Buy |
+517,106
| New | +$10.1M | 0.7% | 31 |
|